Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Copeland

Showing results (531-540 of 573) with videos related to

Pageof 58
Sort By:
Medical Care|April 11, 2018
Near Real-time Surveillance for Consequences of Health Policies Using Sequential AnalysisChristine Y Lu, Robert B Penfold, Sengwee Toh, et al.
ACS Medicinal Chemistry Letters|March 18, 2016
Structure and Property Guided Design in the Identification of PRMT5 Tool Compound EPZ015666Kenneth W Duncan, Nathalie Rioux, P Ann Boriack-Sjodin, et al.
The Lancet. Oncology|April 14, 2018
Tazemetostat, an EZH2 inhibitor, in relapsed or refractory B-cell non-Hodgkin lymphoma and advanced solid tumours: a first-in-human, open-label, phase 1 studyAntoine Italiano, Jean-Charles Soria, Maud Toulmonde, et al.
BMC Psychiatry|February 2, 2020
Chronic pain diagnoses and opioid dispensings among insured individuals with serious mental illnessAshli Owen-Smith, Christine Stewart, Musu M Sesay, et al.
ACS Medicinal Chemistry Letters|May 26, 2015
EPZ011989, A Potent, Orally-Available EZH2 Inhibitor with Robust in Vivo ActivityJohn E Campbell, Kevin W Kuntz, Sarah K Knutson, et al.
Genomics|September 7, 2001
Linkage disequilibrium at the Angelman syndrome gene UBE3A in autism familiesE L Nurmi, Y Bradford, Y Chen, et al.
ACS Medicinal Chemistry Letters|November 19, 2025
Discovery of Kinesin KIF18A Inhibitor ATX020: Tactical Application of Silicon Atom ReplacementBrian A Sparling, Hyelee Lee, Mary-Margaret Zablocki, et al.
Nature Chemical Biology|October 9, 2007
ATP-competitive inhibitors of the mitotic kinesin KSP that function via an allosteric mechanismLusong Luo, Cynthia A Parrish, Neysa Nevins, et al.
Biopharmaceutics & Drug Disposition|January 14, 2014
Nonclinical pharmacokinetics and metabolism of EPZ-5676, a novel DOT1L histone methyltransferase inhibitorAravind Basavapathruni, Edward J Olhava, Scott R Daigle, et al.
Psychiatric Services (Washington, D.C.)|April 16, 2016
Racial-Ethnic Differences in Psychiatric Diagnoses and Treatment Across 11 Health Care Systems in the Mental Health Research NetworkKaren J Coleman, Christine Stewart, Beth E Waitzfelder, et al.
Pageof 58

Showing results (531-540 of 573) with videos related to

Sort By:
Pageof 58
Medical Care|April 11, 2018
Near Real-time Surveillance for Consequences of Health Policies Using Sequential AnalysisChristine Y Lu, Robert B Penfold, Sengwee Toh, et al.
ACS Medicinal Chemistry Letters|March 18, 2016
Structure and Property Guided Design in the Identification of PRMT5 Tool Compound EPZ015666Kenneth W Duncan, Nathalie Rioux, P Ann Boriack-Sjodin, et al.
The Lancet. Oncology|April 14, 2018
Tazemetostat, an EZH2 inhibitor, in relapsed or refractory B-cell non-Hodgkin lymphoma and advanced solid tumours: a first-in-human, open-label, phase 1 studyAntoine Italiano, Jean-Charles Soria, Maud Toulmonde, et al.
BMC Psychiatry|February 2, 2020
Chronic pain diagnoses and opioid dispensings among insured individuals with serious mental illnessAshli Owen-Smith, Christine Stewart, Musu M Sesay, et al.
ACS Medicinal Chemistry Letters|May 26, 2015
EPZ011989, A Potent, Orally-Available EZH2 Inhibitor with Robust in Vivo ActivityJohn E Campbell, Kevin W Kuntz, Sarah K Knutson, et al.
Genomics|September 7, 2001
Linkage disequilibrium at the Angelman syndrome gene UBE3A in autism familiesE L Nurmi, Y Bradford, Y Chen, et al.
ACS Medicinal Chemistry Letters|November 19, 2025
Discovery of Kinesin KIF18A Inhibitor ATX020: Tactical Application of Silicon Atom ReplacementBrian A Sparling, Hyelee Lee, Mary-Margaret Zablocki, et al.
Nature Chemical Biology|October 9, 2007
ATP-competitive inhibitors of the mitotic kinesin KSP that function via an allosteric mechanismLusong Luo, Cynthia A Parrish, Neysa Nevins, et al.
Biopharmaceutics & Drug Disposition|January 14, 2014
Nonclinical pharmacokinetics and metabolism of EPZ-5676, a novel DOT1L histone methyltransferase inhibitorAravind Basavapathruni, Edward J Olhava, Scott R Daigle, et al.
Psychiatric Services (Washington, D.C.)|April 16, 2016
Racial-Ethnic Differences in Psychiatric Diagnoses and Treatment Across 11 Health Care Systems in the Mental Health Research NetworkKaren J Coleman, Christine Stewart, Beth E Waitzfelder, et al.
Pageof 58